Heart Disease Clinical Trials in Detroit

Showing 121-140 of 263 trials

Chronic Total Occlusion Percutaneous Coronary Intervention Study

NCT03988166

The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

Chronic Total OcclusionIschemic Heart DiseaseChronic Total Occlusion of Coronary Artery

Vascular Solutions LLC150 participantsStarted May 2020

Torrance, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +10 more locations

TERMINATEDNA< 1 mile

SHIELD II Clinical Investigation

NCT02468778

The HeartMate PHP System is a temporary (\<6 hours) ventricular assist device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients with severe coronary artery disease, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the HeartMate PHP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri-and post-procedural adverse events.

Coronary Artery Disease

Abbott Medical Devices54 participantsStarted Aug 2015

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +55 more locations

Chronic Total Occlusion Percutaneous Coronary Intervention Study

SHIELD II Clinical Investigation

Heart Disease Trials in Other Cities

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?

The Optimization of Medications in Chronic Heart Failure Using a Website

Early Elimination of Premature Ventricular Contractions in Heart Failure

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Restore EF Observational Study

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

SynCardia 70cc TAH-t for Destination Therapy (DT)

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Other Conditions in Detroit